🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

0.5 Tablet(s) Serving Size
100 Servings
Non-Nutrient/Non-Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 50.0mg (57 products) 📚 17 studies — no high-quality reviews
This product: 25mg UL 50mg

Other Ingredients

Mannitol Cellulose Silica Vegetable Stearate

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (72% of products) Nutrient (2% of products)

Target Groups

Adult (18 - 50 Years) Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested Usage: As a dietary supplement, adults take 1/2 to 1 tablet daily as directed by healthcare professional ONLY! (May be taken sublingually by allowing tablet to dissolve in mouth or with water or juice.)

⚠️ Warnings & Precautions

Tamper resistant package, do not use if outer seal is missing.

WARNING: NOT FOR USE BY INDIVIDUALS UNDER THE AGE OF 18 YEARS.

DO NOT USE IF PREGNANT OR NURSING.

Consult a physician or licensed qualified health care professional before using this product if you have or have a family history of breast cancer, uterine cancer, ovarian cancer, prostate cancer, prostate enlargement, heart disease, low HDL cholesterol (“good cholesterol”), or if you are using any other dietary supplement, prescription drug, or over-the-counter drug. Do not exceed the recommended serving. Exceeding the recommended serving may cause serious adverse health effects. Possible side effects include changes in liver function, acne, hair loss, hair growth on the face (in women), aggressiveness, irritability, and increased levels of estrogen. Discontinue use and call a physician or licensed qualified health care professional immediately if you experience rapid heartbeat, dizziness, blurred vision, or other similar symptoms.

KEEP OUT OF REACH OF CHILDREN.

🧪 Formulation Notes

This product contains NO yeast, wheat gluten, soy protein, milk/dairy, corn, sodium, sugar, starch, artificial coloring, preservatives or flavoring.

Additional Information

For optimal storage conditions, store in a cool, dry place. (59(0)-77(0)F/15(0)-25(0)C) (35-65% relative humidity)

Meets Douglas Laboratories spec [#83050]. Conforms to USP <2091> for weight. Meets USP <2040> for disintegration.

Formula #83050

To report any adverse events call 1-800-332-1088.

Product Details

UPC / SKU 3 10539 00611 5
DSLD Entry Date 2012-06-25
Product Type Non-Nutrient/Non-Botanical
Form Tablet or Pill
DSLD ID 10146
Data Updated 2026-04-11

Research Evidence

30 Research Sources
49 Avg Quality Score
21 Rct
5 Meta Analysis
2 Systematic Review
1 Other
1 Guideline
A Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction
Meta Analysis The Cochrane database of systematic reviews 2024
B Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction
Meta Analysis The Cochrane database of systematic reviews 2015
B The auxiliary effect of oral nutritional supplements on fertility in women with diminished ovarian reserve: a systematic review and meta-analysis
Meta Analysis Annals of medicine 2025
B Impact of dehydroepiandrosterone (DHEA) supplementation on testosterone concentrations and BMI in elderly women: A meta-analysis of randomized controlled trials
Meta Analysis Complementary therapies in medicine 2021
B Supplementation of dehydroepiandrosterone (DHEA) in pre- and postmenopausal women - position statement of expert panel of Polish Menopause and Andropause Society.
Guideline Ginekologia polska 2020
B Effect of Dehydroepiandrosterone and Testosterone Supplementation on Systemic Lipolysis
Rct The Journal of clinical endocrinology and metabolism 2016
C Impact of growth hormone and dehydroepiandrosterone on protein metabolism in glucocorticoid-treated patients
Rct The Journal of clinical endocrinology and metabolism 2008
C Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial.
Rct The lancet. Healthy longevity
C Peculiar observations in measuring testosterone in women treated with oral contraceptives supplemented with dehydroepiandrosterone (DHEA)
Rct Clinica chimica acta; international journal of clinical chemistry 2014
C Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement
Rct The Journal of clinical endocrinology and metabolism 2006
View all evidence for Dhea →

Compare Similar Products

View all Dhea products →